Countries turn to rapid antigen tests to contain second wave of Covid-19

Loading

COURTESY BY: https://www.dawn.com/ ZURICH: Countries straining to contain a second wave of Covid-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly. Germany, where infections jumped by 4,122 on Tuesday to 329,453 total, has secured 9 million so-called antigen tests per month that can deliver a result in minutes and cost about 5 euros ($5.90) each. That would, in theory, cover more than 10pc of the population. The United States and Canada are…

WHO says it trusts G7 to act together on crises amid overhaul talk

Loading

COURTESY BY: https://www.hindustantimes.com/ The World Health Organization trusts powerful nations such as the Group of Seven to reach a consensus on how to approach health crises such as the coronavirus, Mike Ryan, head of WHO’s emergencies programme, said on Monday.   France and Germany have quit talks on reforming the WHO in frustration at attempts by the United States to lead the negotiations, despite its decision to leave the WHO, three officials told Reuters. The move is a setback for President Donald Trump as Washington, which holds the rotating chair…

Japan aims to fast-track review of anti-viral drug remdesivir

Loading

An ampule of Ebola drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany. (Reuters) COURTESY BY: https://www.hindustantimes.com/ Japan will fast-track a review of Gilead Sciences Inc’s antiviral drug remdesivir so that it can hopefully be approved for domestic COVID-19 patients a week after the U.S. firm’s filing for such approval, the health minister said on Saturday. Health Minister Katsunobu Kato’s comment comes after remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday. “I’ve heard…